Ha habido 50 transacciones internas recientes registradas para Citius Pharmaceuticals, Inc. (CTXR), incluyendo 37 compras y 10 ventas. El total de compras internas fue valorado en $5.54M y el total de ventas internas en $11.12M.
Internos destacados con actividad reciente incluyen Holubiak Myron Z, Mazur Leonard L, Mcgrath Dennis M. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — CTXR
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2025-08-08 |
Holubiak Myron Z |
Vice Chairman |
Devolución de Acciones |
31,373 |
$28.75 |
$901.97K |
- |
| 2025-08-08 |
Mazur Leonard L |
Chief Executive Officer |
Devolución de Acciones |
89,388 |
$19.25 |
$1.72M |
- |
| 2024-11-07 |
Holubiak Myron Z |
Vice Chairman |
Concesión de RSU |
75,000 |
$0.38 |
$28.5K |
75,000 |
| 2024-11-07 |
Mcgrath Dennis M |
Director |
Concesión de RSU |
125,000 |
$0.38 |
$47.5K |
125,000 |
| 2024-11-07 |
Mazur Leonard L |
10 Percent Owner, Officer: Chief Executive Officer |
Concesión de RSU |
600,000 |
$0.38 |
$228K |
600,000 |
| 2024-11-07 |
Dutia Suren G |
Director |
Concesión de RSU |
125,000 |
$0.38 |
$47.5K |
125,000 |
| 2024-11-07 |
Webb Carol |
Director |
Concesión de RSU |
125,000 |
$0.38 |
$47.5K |
125,000 |
| 2024-11-07 |
Holuka Eugene Myron |
Director |
Concesión de RSU |
125,000 |
$0.38 |
$47.5K |
125,000 |
| 2024-11-07 |
Bartushak Jaime |
Chief Financial Officer |
Concesión de RSU |
350,000 |
$0.38 |
$133K |
350,000 |
| 2024-11-07 |
Czuczman Myron |
Chief Medical Officer |
Concesión de RSU |
300,000 |
$0.38 |
$114K |
300,000 |
| 2024-11-07 |
Smith Robert Joseph |
Director |
Concesión de RSU |
125,000 |
$0.38 |
$47.5K |
125,000 |
| 2024-09-25 |
Holubiak Myron Z |
Vice Chairman |
Devolución de Acciones |
558,597 |
$0.77 |
$430.12K |
- |
| 2024-09-25 |
Mazur Leonard L |
10 Percent Owner, Officer: Chief Executive Officer |
Devolución de Acciones |
2,234,700 |
$0.77 |
$1.72M |
- |
| 2024-08-14 |
Holubiak Myron Z |
Vice Chairman |
Devolución de Acciones |
784,314 |
$1.15 |
$901.96K |
- |
| 2024-08-14 |
Mazur Leonard L |
10 Percent Owner, Officer: Chief Executive Officer |
Devolución de Acciones |
3,137,255 |
$1.15 |
$3.61M |
- |
| 2024-04-03 |
Holubiak Myron Z |
Vice Chairman |
Devolución de Acciones |
129,450 |
$1.42 |
$183.82K |
- |
| 2024-04-03 |
Mazur Leonard L |
10 Percent Owner, Officer: Chief Executive Officer |
Devolución de Acciones |
1,165,048 |
$1.42 |
$1.65M |
- |
| 2024-03-14 |
Smith Robert Joseph |
Director |
Concesión de RSU |
75,000 |
$0.69 |
$51.75K |
75,000 |
| 2024-03-13 |
Holuka Eugene Myron |
Director |
Ejercicio de Opciones (Venta) |
2,415 |
$0.02 |
$36.23 |
- |
| 2024-03-12 |
Smith Robert Joseph |
Director |
Desconocido |
- |
- |
- |
- |
| 2024-03-04 |
Webb Carol |
Director |
Ejercicio de Opciones (Venta) |
12,071 |
$0.02 |
$181.07 |
- |
| 2023-10-10 |
Holubiak Myron Z |
Vice Chairman |
Concesión de RSU |
400,000 |
$0.70 |
$280K |
400,000 |
| 2023-10-10 |
Mcgrath Dennis M |
Director |
Concesión de RSU |
75,000 |
$0.70 |
$52.5K |
75,000 |
| 2023-10-10 |
Mazur Leonard L |
10 Percent Owner, Officer: Chief Executive Officer |
Concesión de RSU |
550,000 |
$0.70 |
$385K |
550,000 |
| 2023-10-10 |
Dutia Suren G |
Director |
Concesión de RSU |
75,000 |
$0.70 |
$52.5K |
75,000 |
| 2023-10-10 |
Webb Carol |
Director |
Concesión de RSU |
75,000 |
$0.70 |
$52.5K |
75,000 |
| 2023-10-10 |
Holuka Eugene Myron |
Director |
Concesión de RSU |
75,000 |
$0.70 |
$52.5K |
75,000 |
| 2023-10-10 |
Bartushak Jaime |
Chief Financial Officer |
Concesión de RSU |
300,000 |
$0.70 |
$210K |
300,000 |
| 2023-10-10 |
Czuczman Myron |
Chief Medical Officer |
Concesión de RSU |
300,000 |
$0.70 |
$210K |
300,000 |
| 2023-02-07 |
Mcgrath Dennis M |
Director |
Desconocido |
- |
- |
- |
- |
| 2023-02-07 |
Mcgrath Dennis M |
Director |
Concesión de RSU |
75,000 |
$1.42 |
$106.5K |
75,000 |
| 2022-10-04 |
Holubiak Myron Z |
Vice Chairman |
Concesión de RSU |
400,000 |
- |
- |
400,000 |
| 2022-10-04 |
Safir Howard |
Director |
Concesión de RSU |
75,000 |
- |
- |
75,000 |
| 2022-10-04 |
Mazur Leonard L |
Executive Chairman |
Concesión de RSU |
550,000 |
- |
- |
550,000 |
| 2022-10-04 |
Dutia Suren G |
Director |
Concesión de RSU |
75,000 |
- |
- |
75,000 |
| 2022-10-04 |
Webb Carol |
Director |
Concesión de RSU |
75,000 |
- |
- |
75,000 |
| 2022-10-04 |
Kane William |
Director |
Concesión de RSU |
75,000 |
- |
- |
75,000 |
| 2022-10-04 |
Holuka Eugene Myron |
Director |
Concesión de RSU |
75,000 |
- |
- |
75,000 |
| 2022-10-04 |
Bartushak Jaime |
Chief Financial Officer |
Concesión de RSU |
300,000 |
- |
- |
300,000 |
| 2022-10-04 |
Czuczman Myron |
Chief Medical Officer |
Concesión de RSU |
300,000 |
- |
- |
300,000 |
| 2022-10-04 |
Mazur Leonard L |
10 Percent Owner, Officer: Executive Chairman |
Desconocido |
- |
- |
- |
- |
| 2021-10-11 |
Holubiak Myron Z |
President and CEO |
Concesión de RSU |
15,000 |
$2.04 |
$30.6K |
15,000 |
| 2021-10-11 |
Safir Howard |
Director |
Concesión de RSU |
75,000 |
$2.04 |
$153K |
75,000 |
| 2021-10-11 |
Mazur Leonard L |
10 Percent Owner, Officer: Executive Chairman |
Concesión de RSU |
650,000 |
$2.04 |
$1.33M |
650,000 |
| 2021-10-11 |
Dutia Suren G |
Director |
Concesión de RSU |
75,000 |
$2.04 |
$153K |
75,000 |
| 2021-10-11 |
Webb Carol |
Director |
Concesión de RSU |
75,000 |
$2.04 |
$153K |
75,000 |
| 2021-10-11 |
Kane William |
Director |
Concesión de RSU |
75,000 |
$2.04 |
$153K |
75,000 |
| 2021-10-11 |
Holuka Eugene Myron |
Director |
Concesión de RSU |
75,000 |
$2.04 |
$153K |
75,000 |
| 2021-10-11 |
Bartushak Jaime |
Chief Financial Officer |
Concesión de RSU |
300,000 |
$2.04 |
$612K |
300,000 |
| 2021-10-11 |
Czuczman Myron |
Chief Medical Officer |
Concesión de RSU |
300,000 |
$2.04 |
$612K |
300,000 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
